Pharmaceutical Manufacturing – 0.9% Sodium Chloride Injection, 250 mL

The contract requires the manufacture, quality control, and packaging of sterile 0.9% Sodium Chloride Injection in 250 mL volumes, strictly adhering to USP standards, current Good Manufacturing Practices, and Department of Defense Logistics Agency requirements. The product must be produced in a controlled, sterile environment to ensure safety and efficacy for medical use, with comprehensive testing protocols to validate purity, potency, and absence of pyrogens or particulate contamination throughout the production cycle. Packaging must meet all regulatory and logistical specifications for distribution within military healthcare systems. The solicitation is issued under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing by the Department of Defense through its Medical Supply Chain Pharm FSA office, and performance is designated to occur at Fort Campbell with a zip code of 42223-5000. The opportunity is classified as a subcontract with no set-aside designation, open to qualified suppliers capable of meeting rigorous federal pharmaceutical standards. Although no point of contact is listed, responses must be submitted by the deadline of July 27, 2026, following the procurement portal available via the provided DIBBS link.